AATB Learning
2024 Webinar Series: Overview of scCO2 and E-beam Sterilization Methods for Human cells, Tissues, Cellular and Tissue-based Products (HCT/Ps) (Individual)
-
Register
- Non-member - $150
- Member - $50
Description: This webinar will provide an overview of two important sterilization methods used for Human cells, tissues, and cellular and tissue-based products (HCT/Ps). This includes an introduction to the technology, feasibility and applications, and considerations for their use and adoption.
Target Audience: This webinar is designed for tissue bank professionals with expertise in regulatory, quality, processing, and distribution. It is also designed for professionals with an interest in sterilization methods for Human cells, tissues, and cellular and tissue-based products.
Jeff Sauter
Director Business Development
SteriTek
As Director of Business Development at Steri-Tek, Jeff Sauter is focused on collaborating with medtech and biotech innovators in helping achieve optimal E-beam/X-Ray sterilization and processing throughput of their medical device, combination device, drug/biologic products. Jeff has 15+ years’ experience consulting within the medical device and biotech arenas. Jeff holds a bachelor’s degree in economics at the University of Illinois-Chicago.
Aaron Strickland, PhD
CEO and Co-founder
NovaSterilis, Inc.
Aaron Strickland is the Co-founderand VP of R&D of iFyber, the parent company to NovaSterilis where he servesas their Chief Science Officer. Aaronhas over 20 years of research experience across a diverse array of fields,including synthetic chemistry, analytical chemistry, microbiology and molecularbiology, and nanotechnology. Aaron leads multidisciplinary teams as theprincipal investigator and study director on both corporate-funded projects andfederal grants and contracts for numerous federal agencies. Aaron is currently leading an NIH-fundedeffort to explore scCO2-basedsterilization of drug substances and drug products.
Aaron received his Ph.D. inchemistry from the University of Wyoming and performed postdoctoral work inmicrobiology and biotechnology at Cornell University as a National ScienceFoundation Fellow.